B+ = MoonshotScore 41[multi-pillar formula] + Council 4/6[6-lens rule]. Form 4: 0 transactions[FMP Form 4].
Quick AnswerCRH plc (CRH) Q2 consensus: revenue $11.6B[FMP est], EPS $2.30[FMP est]. 1 consecutive quarters of beat[FMP earnings].
Content generated by AI editorial engine. Editorially supervised by Sedat ANAK.
3 analysts' median target is $132[FMP target], stock is $101, +31.2% vs the analyst consensus median. After Q2 +9.4% EPS beat[FMP earnings], the stock moved -1.0%.
B+ = MoonshotScore 41[multi-pillar formula] + Council 4/6[6-lens rule]. Form 4: 0 transactions[FMP Form 4].
Quick AnswerCRH plc (CRH) Q2 consensus: revenue $11.6B[FMP est], EPS $2.30[FMP est]. 1 consecutive quarters of beat[FMP earnings].
Q2 EPS +9.4% beat[FMP] but the stock -1.0% D+1[FMP D+1].
Watchlist
Fy26 Ebitda Guidance
fy26_ebitda_guidance
CRH reaffirmed its adjusted EBITDA guidance for 2026 to be between $8.1 billion and $8.5 billion, despite current geopolitical and macroeconomic uncertainties.
"Notwithstanding the current geopolitical and macroeconomic uncertainties, we are pleased to reaffirm our adjusted EBITDA guidance range for 2026, representing another strong year of growth and value creation for CRH. ... we expect full year adjusted EBITDA to be between $8.1 billion and $8.5 billion, net income between $3.9 billion and $4.1 billion and diluted earnings per share between $5.60 and $6.05, representing another strong year of growth and value creation for CRH."
- Jim Mintern, CEO - Q2 FY26 Earnings Call - July 30, 2026
Q2 Financial Performance
q2_financial_performance
CRH delivered a robust performance in Q2 with a 6% revenue increase and a 7% adjusted EBITDA growth, achieving 30 basis points of margin expansion despite a challenging inflationary environment.
"Total revenues of $10.8 billion were 6% ahead. This translated into adjusted EBITDA of over $2.6 billion in the quarter, a 7% increase over the prior year. Despite contending with an inflationary cost environment, I am pleased to report a further 30 basis points of margin expansion, demonstrating our relentless focus on commercial excellence and strong cost discipline across our business."
- Jim Mintern, CEO - Q2 FY26 Earnings Call - July 30, 2026
Arcosa Acquisition
arcosa_acquisition
CRH announced an agreement to acquire Arcosa for an enterprise value of approximately $8.5 billion, which will reinforce its position as a leading infrastructure player in North America and add 35 million tonnes of annual high-quality aggregates production.
"We also recently announced an agreement to acquire Arcosa, a leading provider of building materials and critical infrastructure products in the United States. This is a significant investment, which will reinforce CRH as the leading aggregates and critical infrastructure player in North America, and I will take you through that in further detail later in the presentation. ... in June, we also reached an agreement to acquire Arcosa for a cash consideration of $150 per share, reflecting a total enterprise value of approximately $8.5 billion. ... with 35 million tonnes of annual high-quality aggregates, it will reinforce our position as the leader in U.S. aggregates with over 265 million tonnes of combined annualized production."
- Jim Mintern, CEO - Q2 FY26 Earnings Call - July 30, 2026
Capital Allocation Strategy
capital_allocation_strategy
CRH has invested $1.4 billion in 17 acquisitions year-to-date and sees a strong M&A pipeline, planning to allocate approximately 70% of its financial capacity to future growth investments.
"year-to-date, we've invested $1.4 billion on 17 value-accretive acquisitions across our connected growth platforms. ... Looking ahead and notwithstanding what has been an active year so far, we have a strong pipeline of further M&A opportunities in front of us, supported by our unmatched scale, connected portfolio and fragmented nature of our industry. ... over the next 5 years, we expect to have at our disposal financial capacity of approximately $40 billion. We expect to allocate approximately 70% of this to growth investments with the remaining 30% returned to shareholders through dividends and share buybacks."
- Aylwyn Bryan, CFO - Q2 FY26 Earnings Call - July 30, 2026
Americas Building Solutions Challenges
americas_building_solutions_challenges
The Americas Building Solutions segment experienced a decline in Q2 revenues and EBITDA due to divestitures, a subdued new build residential market, and elevated haulage rates.
"Next to Americas Building Solutions on Slide 8, where our second quarter performance reflects the impact of recently completed divestitures and a subdued new build residential market. We also experienced an inflationary cost backdrop, particularly in relation to elevated haulage rates in the quarter, and we've implemented operational and commercial initiatives to mitigate these costs. ... For Americas Building Solutions overall, total revenues and adjusted EBITDA were 2% and 8% behind prior year."
- Randy Lake, COO - Q2 FY26 Earnings Call - July 30, 2026
Arcosa Synergies
arcosa_synergies
The Arcosa acquisition is expected to generate approximately $175 million in run-rate cost synergies by year 3, with $60 million anticipated in the first year of ownership.
"And as you can see on Slide 15, we currently expect approximately $175 million of run-rate cost synergies to be achieved by year 3 with $60 million anticipated in the first year of ownership."
- Randy Lake, COO - Q2 FY26 Earnings Call - July 30, 2026
Stock Expert AI - Methodology
multi-pillar methodology. Cash Runway and News Sentiment strong. Revenue Growth weak.
How is it calculated? ->6 investor frameworks. 4 bullish (Ray Dalio, Klarman, Buffett, Munger), 1 bearish (Ken Griffin), 1 neutral (Jim Simons).
How is it calculated? ->Quality business, discounted price.
How is it calculated? ->Past Performance
Q2 (July 30, 2026): EPS $2.21 vs $2.02 est[FMP], +9.4% beat. D+1 movement: -1.0%[FMP D+1]. Decline despite beat - market reacted to guidance, not numbers.
Q2: EPS $2.21 vs $2.02 beat[FMP], stock -1.0% D+1[FMP]. Aylwyn Bryan Q2 transcript: "Notwithstanding the current geopolitical and macroeconomic uncertainties, we are pleased to reaffirm our adjusted EBITDA guidance range for 2026, representing another strong year of growth and value creation for CRH. ... we expect full year adjusted EBITDA to be between $8.1 billion and $8.5 billion, net income between $3.9 billion and $4.1 billion and diluted earnings per share between $5.60 and $6.05, representing another strong year of growth and value creation for CRH."[Aylwyn Bryan].
"Notwithstanding the current geopolitical and macroeconomic uncertainties, we are pleased to reaffirm our adjusted EBITDA guidance range for 2026, representing another strong year of growth and value creation for CRH. ... we expect full year adjusted EBITDA to be between $8.1 billion and $8.5 billion, net income between $3.9 billion and $4.1 billion and diluted earnings per share between $5.60 and $6.05, representing another strong year of growth and value creation for CRH."
- Aylwyn Bryan, CFO - Q2 FY26 Earnings Call - July 30, 2026
No RPO/backlog concentration disclosed in Q2 earnings call.
Q2 CapEx $639.0M[FMP cashflow]. Q2 op margin 19.3%[FMP op margin] - this level in Q2 is sensitive to CapEx revision risk.
"Through the second quarter, we've invested approximately $800 million in growth CapEx leveraging our size and scale to fully capitalize on high-returning, low-risk investment opportunities to expand capacity in high-growth markets, improve operational efficiency, increase automation and optimize our energy usage, all of which will drive long-term shareholder value."
- Aylwyn Bryan, CFO - Q2 FY26 Earnings Call - July 30, 2026
Not advice - a structural framework for earnings night. Decision discipline is yours.
Market Outlook
You read it in 5 minutes. When the numbers come out on Wednesday evening - you know what you're looking at.
Data arrives at night. The framework is ready now.
Data arrives on Wednesday evening. The framework is ready on this page: Q2 EPS threshold $2.30[FMP], CapEx threshold "below $639.0M". Two anchors, three scenarios.
Comparison Stock Expert AI is free today — no credit card.
Seeking Alpha $299/yr - analyst opinions + earnings coverage TipRanks $360/yr - Smart Score (1-10) + analyst consensus + insider trades Trendspider $400/yr - AI pattern detection + automated TA + multi-timeframe alerts
Prices as of April 2026. Sources: seekingalpha.com/subscriptions - tipranks.com/pricing - trendspider.com/pricing
Stock Expert AI is free today — no credit card. Council 7-lens analysis + MoonshotScore multi-pillar + Insider tracker + Technical levels - all in one platform, for every stock.
Educational tool, not investment advice. Past performance does not guarantee future results.
Calendar
DATA GAP: Events not in the FMP /stable/calendar feed - Investor day, analyst day, product launches, regulatory dates. These require company IR page scraping or manual calendar entry.
This CRH plc (CRH) earnings preview covers the analyst consensus, key catalysts, and what to watch on the earnings call.
CRH plc (CRH): Consensus EPS, revenue guidance, segment growth rates, and the tone of management commentary — the full breakdown with sources is on this page.
CRH plc (CRH): Figures are sourced from Financial Modeling Prep (FMP) fundamentals and consensus data plus official earnings-call transcripts; derived metrics are labeled with their source next to each figure.
CRH plc (CRH): No. This page is educational research, not investment advice. It summarizes analyst consensus and company data; consult a licensed financial advisor before making any investment decision.